Revelar Biotherapeutics

Revelar Biotherapeutics is a biopharmaceutical company focused on developing and commercializing breakthrough therapeutic antibody products to address critical unmet patient needs in COVID-19 and other therapeutic areas. The management team of Revelar Biotherapeutics possesses deep expertise and a proven track record in high-quality clinical development, regulatory affairs, CMC, business development, and operations with leading global pharmaceutical companies. The company’s therapeutic areas of interest include oncology, autoimmune diseases, and infectious diseases. Revelar seeks to combine its clinical development and commercialization capabilities with Twist’s unique and innovative technology platform, as well as the brightest minds from industry and academia, to unlock new target classes and accelerate the discovery and delivery of transformative antibody therapies to meet unmet patient needs.